Upper Respiratory Tract Infections Clinical Trial
— INCREASEOfficial title:
Innate Immune Response to Anaerobe and Aerobe Exercise in Rowing Athletes
Exercise induces innate immune response activation in athletes. The response starts during
exercise and lasts for approximately 24 hours. This innate immune response shows
similarities to the innate immune activation observed in, for example, bacterial infection
and trauma. Immediately after exercise, athletes develop leukocytosis and cytokine
production is altered towards an inflammatory pattern. However, to gain insight in immune
response, a detailed cell receptor expression is required. To investigate the physiological
innate immune response to exercise, we developed a model in rowers.
Aim: To determine the type and degree of cellular inflammatory response in peripheral blood
of elite rowing athletes after both anaerobe and aerobe exercise.
Study design:
Investigator driven, monocenter observational pilot study.
Study population: 16 healthy, non-asthmatic, human volunteers, 18-25 year old. All
competitive rowing athletes.
Status | Completed |
Enrollment | 16 |
Est. completion date | December 2013 |
Est. primary completion date | December 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 25 Years |
Eligibility |
Inclusion Criteria: - Elite rower: rowing for 12 months or longer, >6 times a week. - Aged 18-25 years - Pretested(by exercise test*) maximum heart rate - Visiting Rowing club Triton, Orca or Viking - Performed a sports medical examination test (required for competing on a national level by the Royal Dutch Rowing Asscociation) *The exercise test is a multi step power test which builds up to maximum effort. Exclusion Criteria: - Asthmatic - Current respiratory infection, sinusitis, otitis or any other sign of acute/ chronic inflammatory disease - Physically injured |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Netherlands | Rowing Centre "De Driewerf" | Utrecht |
Lead Sponsor | Collaborator |
---|---|
UMC Utrecht |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Differences between anaerobic and aerobic exercise in neutrophil surface marker expression, functionality of neutrophils and absolute cell counts (granulocytes, lymphocytes and monocytes) | Compare the peripheral blood leukocyte characteristics in the context of anaerobic versus aerobic exercise challenge Surface marker expression Functional differences Absolute cell counts |
pre, 0h, 2h, 4h | No |
Primary | Change in neutrophil surface marker expression profiles over time | FACS analysis of peripheral blood neutrophils. The changes in surface markers over time will be analysed by principal component analysis. | pre, 0h, 2h and 4h | No |
Secondary | Functional differences of neutrophil phenotypes before versus neutrophils that appear after exercise | Neutrophils: Oxidative burst, killing capacity of St. Aureus, chemotaxis | pre and 2h post | No |
Secondary | Changes in absolute cell count | Measuring the change in absolute cell count (granulocytes, lymphocytes, monocytes) over time. Timepoint 'pre' is considered to be the basal level and 0, 2 and 4h as points of change. Repeated measures ANOVA will be used to detect the change. | pre, 0, 2h and 4h | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01158560 -
A Trial of Vitamin D and Health Advice for the Prevention of Upper Respiratory Tract Infections
|
Phase 3 | |
Completed |
NCT00965822 -
A Randomized, Double-blind, Placebo-controlled Study on the Efficacy and Safety of CVT-E002 in the Treatment of Upper Respiratory Tract Infections in a Pediatric (3-11 Years) Population
|
Phase 2 | |
Completed |
NCT01019889 -
Effect of Socheongryong-tang and Yeongyopaedok-san in Upper Respiratory Tract Infection
|
Phase 3 | |
Not yet recruiting |
NCT05484102 -
Preventive Effect of Cow's Milk Fermented With Lactobacillus Paracasei CBA L74 on Common Infectious Diseases in Children
|
N/A | |
Recruiting |
NCT05804123 -
LiveSpo Navax® Supports the Treatment of Acute Rhinosinusitis and Otitis Media
|
N/A | |
Completed |
NCT01773824 -
Routine Prescription Feedback and Peer Comparison to Lower Antibiotic Prescriptions in Primary Care
|
N/A | |
Terminated |
NCT01964885 -
Benefit and Tolerability of IQP-AS-105 in Reducing Susceptibility to Upper Respiratory Tract Infections
|
Phase 3 | |
Completed |
NCT01883427 -
Nasal Spray With Glucose Oxidase Preventing Common Cold in Pre-school Children
|
Phase 2 | |
Completed |
NCT01215682 -
Vitamin D Supplementation and Upper Respiratory Tract Infections in Adolescent Swimmers
|
N/A | |
Completed |
NCT04019730 -
The Effect of a Ketogenic Diet on the Exercise Induced Immune Response
|
N/A | |
Completed |
NCT01604096 -
Controlled Trial to Evaluate a Local Information Campaign on Antibiotic Prescribing in Italy
|
Phase 2 | |
Recruiting |
NCT06149494 -
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
|
Phase 2 | |
Completed |
NCT03463694 -
Edinburgh and Lothian Virus Intervention Study in Kids
|
N/A | |
Completed |
NCT06127186 -
Phenotype of Headache and Facial Pain in Upper Respiratory Tract Infections
|
||
Completed |
NCT03198676 -
A Safety Study to Compare the Effect of Two PrEP-001 Nasal Powder Formulations on Nasal Mucosa and Serum Cytokine Production
|
Phase 1 | |
Withdrawn |
NCT05557214 -
Reducing Unnecessary Antibiotic Prescriptions in Primary Healthcare in Saskatchewan by Identifying High Prescribers
|
N/A | |
Completed |
NCT01396889 -
Impact of Echinacea as Prophilaxis for Upper Respiratory Tract Infections in Children 1-5 Years
|
N/A | |
Completed |
NCT01129128 -
Three Arm Trial of Immune Effects of Echinacea
|
N/A | |
Completed |
NCT05252468 -
COVID-19 Prevention Trial: Effect of Prophylactic Use of TAFFIX™ on Infection Rate by SARS-CoV-2 Virus (COVID-19).
|
N/A | |
Terminated |
NCT05279534 -
Efficacy and Safety of L. Plantarum and P. Acidilactici in Children With Upper Respiratory Tract Infections
|
N/A |